The effect of intensive treatment of hypertension on cardiovascular events, generalized to middle-aged to older Americans living with hypertension
- 26 December 2024
- journal article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (11) , 3185-3194
Abstract
The Systolic Blood Pressure Intervention Trial (SPRINT) estimated the effect of intensive systolic blood pressure treatment (target <120 mm Hg) compared to standard (<140 mm Hg) on the risk of cardiovascular events in adults aged 50 years and older. Clinical trial participants may differ from an intervention’s target population. We generalized the SPRINT results to US adults who would qualify for treatment under SPRINT eligibility criteria. We applied these eligibility criteria to participants of the National Health and Nutrition Examination Survey (NHANES) from 2011–2018 to describe the target population. We estimated Cox proportional hazards models and Kaplan–Meier risk curves, weighted with the inverse odds of sampling, to estimate hazards ratios (HRs) and 5-year risk differences for the effect of intensive treatment on cardiovascular and adverse events in the target population. The HR for cardiovascular disease events was 0.76 (95% confidence interval [CI]: 0.53, 1.08) comparing intensive to standard treatment, which is consistent with the estimates from the original SPRINT trial. The 5-year risk difference for a cardiovascular event was $-$2.2% (95% CI: $-$5.3%, 1.6%). The HR for serious adverse events was 0.97 (95% CI: 0.83, 1.13). Despite differences between the SPRINT and target populations, we estimated a similar benefit of intensive treatment and similar rates of SAEs, in the target population.Keywords
This publication has 26 references indexed in Scilit:
- Balancing Benefit and Harm of Intensive Blood Pressure Lowering Based on Individual Outcome Profile AnalysisThe American Journal of Medicine, 2023
- Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)The American Journal of Cardiology, 2021
- Generalizing randomized trial findings to a target population using complex survey population dataStatistics in Medicine, 2020
- Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOMENature Reviews Endocrinology, 2017
- Generalizability of SPRINT Results to the U.S. Adult PopulationJACC, 2016
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- The AUDIT Alcohol Consumption Questions (AUDIT-C)An Effective Brief Screening Test for Problem DrinkingArchives of internal medicine (1960), 1998